29th May 2013 08:59
AEC Education: WH Ireland lowers target price from 16p to 11p retaining a buy recommendation. Bodycote: JP Morgan downgrades to underweight with a target price of 495p. BTG: Deutsche Bank ups target price from 440p to 475p retaining a buy recommendation. De La Rue: Investec raises target price fr
Read more24th May 2013 11:19
Shares of BTG have been held back since the start of the year due to concerns regarding impending acquisitions. Nevertheless, now that these - and a 106.3m pound capital issue - are out of the way the stock should progress, says The Times's Tempus. The company will acquire North America based Ekos a
Read more23rd May 2013 08:35
Amara Mining: Numis lowers target price from 80p to 70p, while keeping a buy recommendation. ARM Holdings: Exane downgrades to neutral with a target price of 1000p. Aveva: Panmure Gordon raises target price from 1900p to 2076p and retains a hold recommendation. Canaccord Genuity increases target p
Read more23rd May 2013 08:35
BTG, the specialist healthcare company, has entered into an agreement to buy EKOS Corporation (EKOS), an interventional vascular business, and separately to buy the Targeted Therapies division of Nordion. Targeted Therapies will be purchased for a total cash consideration of around £133m. This w
Read more21st May 2013 07:12
Antofagasta: Canaccord Genuity reduces target price from 1065p to 1040p, while leaving its hold recommendation unchanged. Barratt Developments: Goldman Sachs takes target price from 351p to 371p maintaining a buy recommendation. Big Yellow Group: Investec increases target price from 370p to 430p a
Read more20th May 2013 15:51
Transport firm FirstGroup led the fallers after cancelling its final dividend as it restructured its balance sheet and refinanced after a year in which operating profits halved. In results announced two days earlier than scheduled, the company announced a three-for-two rights issue as well as the re
Read more20th May 2013 07:36
International specialist healthcare firm BTG posted a robust set of annual figures following a strong performance in its specialty pharmaceuticals business, increased royalties from licensed products and after it moved to direct sales of its interventional oncology products in the US. The group, wh
Read more12th Apr 2013 08:25
BTG, an international specialist healthcare company, has announced that the US Food & Drug Administration (FDA) has accepted the new drug application for the group's Varisolve product. The application for the varicose vein treatment was submitted on February 4th of this year, and has been accepted
Read more10th Apr 2013 08:57
African Barrick Gold: Westhouse Securities upgrades from sell to neutral with a target price of 195p. Deutsche Bank reduces target price from 340p to 230p keeping its hold rating. African Minerals: Deutsche Bank reduces target price from 620p to 594p and leaves its buy recommendation unaltered. An
Read more5th Apr 2013 08:33
Aberdeen Asset Management: Jefferies moves target price from 400p to 420p keeping a hold recommendation. Aggreko: Investec reduces target price from 2065p to 1900p downgrading from buy to add. APR Energy: Investec takes target price from 650p to 900p retaining a hold recommendation. ARM Holdings:
Read more5th Apr 2013 07:37
The gyrations in shares of international engineering services group AMEC are a good example of just how nervous financial markets are. In February they plunged by 6 per cent after guiding towards revenue growth in the low to mid-single-digit range. Yet yesterday they rose against the backdrop of a f
Read more4th Apr 2013 11:19
The FTSE 100 was little changed by Thursday lunchtime as the Bank of England (BoE) voted to monetary policy on hold, as all eyes turn to the European Central Bank (ECB) ahead of its policy decision in the coming hours. Traders also had to digest a number of mixed economic indicators this morning, w
Read more4th Apr 2013 08:45
Markets opened slightly lower in London on Thursday despite a much-welcome boost for the Japanese economy announced overnight, as investors kept their powder dry ahead of policy decisions from the Bank of England (BoE) and the European Central Bank (ECB) this afternoon. The Bank of Japan (BoJ) anno
Read more4th Apr 2013 07:43
Healthcare company BTG said on Thursday it has delivered robust full-year results driven by sales across its speciality pharmaceuticals and licensing and biotechnology divisions. The group expects revenue of £230m for the year ended March 31st 2013, according to a trading update ahead of the annua
Read more1st Feb 2013 07:07
Royal Dutch Shell's fourth-quarter results were a mixed bag. In the final quarter of last year, profits on a current cost of supply basis - which strip out the effect of movements in the oil price on inventories - rose 15 per cent to 5.58bn dollars (3.5bn pounds), lower than a consensus view of 6.2b
Read more